Explore 12 Jubilant, Jubilant Life, and more!

Explore related topics

Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has announced that its wholly own subsidiary Jubilant Pharma Limited, through one of its units Jubilant DraxImage Inc.

Jubilant Life Sciences Ltd, an integrated global Pharmaceuticals and Life Sciences Company, has announced that its wholly own subsidiary Jubilant Pharma Limited, through one of its units Jubilant DraxImage Inc.

Jubilant Life Science jumped 2% to Rs.415.60 on BSE. The pharma company received USFDA approval for generic Celexa, as per media reports. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/jubilant-life-science-jumps-2-after.html#sthash.A3SA233q.dpuf

Jubilant Life Science jumped 2% to Rs.415.60 on BSE. The pharma company received USFDA approval for generic Celexa, as per media reports. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/jubilant-life-science-jumps-2-after.html#sthash.A3SA233q.dpuf

Jubilant Life Sciences gained 2.7% to Rs.431. The Reserve Bank of India has allowed foreign investors to pick up to 45% in Jubilant Life Sciences under the portfolio investment scheme. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/jubilant-life-sciences-gains-27-foreign.html#sthash.zdQI6P5r.dpuf

Jubilant Life Sciences gained 2.7% to Rs.431. The Reserve Bank of India has allowed foreign investors to pick up to 45% in Jubilant Life Sciences under the portfolio investment scheme. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/jubilant-life-sciences-gains-27-foreign.html#sthash.zdQI6P5r.dpuf

Shares of Jubilant FoodWorks BSE 1.12 % slumped to their lowest level since February on Tuesday after its chief executive officer and whole-time director Ajay Kaul resigned. The stock lost 6% to end at `944.15 on the BSE

Shares of Jubilant FoodWorks BSE 1.12 % slumped to their lowest level since February on Tuesday after its chief executive officer and whole-time director Ajay Kaul resigned. The stock lost 6% to end at `944.15 on the BSE

Smallcap IT company NIIT Technologies is expected to report a loss of Rs 14.5 crore for the quarter ended March against profit of Rs 48.2 crore in December quarter. Revenue is likely to be flat at Rs 596 crore during January-March quarter compared to Rs 595.3 crore in previous quarter.

Smallcap IT company NIIT Technologies is expected to report a loss of Rs 14.5 crore for the quarter ended March against profit of Rs 48.2 crore in December quarter. Revenue is likely to be flat at Rs 596 crore during January-March quarter compared to Rs 595.3 crore in previous quarter.

SJVN Ltd has informed BSE that the company has signed a Memorandum of Understanding (MoU) on December 3, 2015 - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/sjvn-inks-mou-with-saurya-urja-company.html#sthash.Rba9AbbL.dpuf

SJVN Ltd has informed BSE that the company has signed a Memorandum of Understanding (MoU) on December 3, 2015 - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/sjvn-inks-mou-with-saurya-urja-company.html#sthash.Rba9AbbL.dpuf

Central Bank of India surges on BSE index, after its board approved raising over Rs 165 crore by issuing additional equity shares to insurance giant LIC - See more at: http://ways2capital-equitytips.blogspot.in/2016/03/central-bank-of-india-gains-2-issues.html#sthash.v2JdvDXA.dpuf

Central Bank of India surges on BSE index, after its board approved raising over Rs 165 crore by issuing additional equity shares to insurance giant LIC - See more at: http://ways2capital-equitytips.blogspot.in/2016/03/central-bank-of-india-gains-2-issues.html#sthash.v2JdvDXA.dpuf

United Bank of India has announced that at the meeting of the Board of Director scheduled to be held on December 18, 2015, the proposal to raise Equity Capital by Preferential Allotment up to Rs. 1500cr - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/united-bank-of-india-to-raise-rs-1500.html#sthash.xlmYRwzC.dpuf

United Bank of India has announced that at the meeting of the Board of Director scheduled to be held on December 18, 2015, the proposal to raise Equity Capital by Preferential Allotment up to Rs. 1500cr - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/united-bank-of-india-to-raise-rs-1500.html#sthash.xlmYRwzC.dpuf

The seventh largest generic company by volume in US markets, Aurobindo Pharma, has released its investor presentation to be submitted in JP Morgan Healthcare conference, starting today.

The seventh largest generic company by volume in US markets, Aurobindo Pharma, has released its investor presentation to be submitted in JP Morgan Healthcare conference, starting today.

Power Finance Corporation has announced that the Board of Directors of the Company at its meeting held on December 16, 2015, inter alia, have declared and approved the payment of interim dividend @ Rs.8.80/- per equity share on the face value of the paid-up equity shares of Rs.10/- each for the Financial Year 2015-16. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/pfc-declares-interim-dividend-of-rs-880.html#sthash.mw1npZsO.dpuf

Power Finance Corporation has announced that the Board of Directors of the Company at its meeting held on December 16, 2015, inter alia, have declared and approved the payment of interim dividend @ Rs.8.80/- per equity share on the face value of the paid-up equity shares of Rs.10/- each for the Financial Year 2015-16. - See more at: http://ways2capital-equitytips.blogspot.in/2015/12/pfc-declares-interim-dividend-of-rs-880.html#sthash.mw1npZsO.dpuf

Pinterest
Search